Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1157]

Comparing adjuvant radiotherapy plus chemo vs. adjuvant chemo following...

Dr Brian Baumann - University of Pennsylvania, Philadelphia, USA

Comparing adjuvant radiotherapy plus chemo vs. adjuvant chemo following cystectomy for bladder cancer ( Dr Brian Baumann - University of Pennsylvania, Philadelphia, USA )

Molecular genetics of testicular cancer: What does the clinician need to know?

Dr Katherine Nathanson - University of Pennsylvania, Philadelphia, USA

Molecular genetics of testicular cancer: What does the clinician need to know? ( Dr Katherine Nathanson - University of Pennsylvania, Philadelphia, USA )

New treatment options in metastatic prostate cancer

Dr Neal Shore and Dr Axel Merseburger

New treatment options in metastatic prostate cancer ( Dr Neal Shore and Dr Axel Merseburger )

ASCO GU 2016: Highlights

Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA

ASCO GU 2016: Highlights ( Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA )

Atezolizumab for platinum-treated locally advanced or metastatic urothelial...

Dr Jean Hoffman-Censits - Kimmel Cancer Center, Philadelphia, USA

Atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma ( Dr Jean Hoffman-Censits - Kimmel Cancer Center, Philadelphia, USA )

Healthcare and QoL burden of symptomatic skeletal events in CRPC with bone mets

Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA

Healthcare and QoL burden of symptomatic skeletal events in CRPC with bone mets ( Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA )

Regular aspirin use may reduce risk of dying from prostate cancer

Dr Christophe Allard - Massachusetts General Hospital, Boston, USA

Regular aspirin use may reduce risk of dying from prostate cancer ( Dr Christophe Allard - Massachusetts General Hospital, Boston, USA )

Celecoxib with or without zoledronic acid for hormone-naïve prostate cancer

Prof Eleni Efstathiou and Prof Nick James

Celecoxib with or without zoledronic acid for hormone-naïve prostate cancer ( Prof Eleni Efstathiou and Prof Nick James )

Link between non-aspirin NSAID use and risk of developing renal cell cancer

Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA

Link between non-aspirin NSAID use and risk of developing renal cell cancer ( Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA )

Brentuximab vedotin as salvage therapy for men with relapsed germ-cell tumours

Dr Andrea Necchi - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Brentuximab vedotin as salvage therapy for men with relapsed germ-cell tumours ( Dr Andrea Necchi - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy )

Actionable targets in patients with cisplatin-resistant advanced germ cell...

Dr Aditya Bagrodia - Memorial Sloan Kettering New York, USA

Actionable targets in patients with cisplatin-resistant advanced germ cell tumours ( Dr Aditya Bagrodia - Memorial Sloan Kettering New York, USA )

What does the iManageCancer project hope to achieve?

Prof Gordon McVie - ecancer Managing Editor

What does the iManageCancer project hope to achieve? ( Prof Gordon McVie - ecancer Managing Editor )

More from ecancer